The synthetic version of exendin-4, exenatide, shares a 53% amino acid sequence homology with human GLP-1 [18] and has been investigated in treating PD
Regulatory Notice This compound has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any condition
Dmitrieva AI et al
Semaglutide mimics one natural hormone related to appetite suppression and stabilizing blood sugar
however, only protein potentiated the second-phase insulin response [27]
They're marketed as being cheaper, easier to use, and available to anyone, unlike prescription weight loss injections, which require a consultation and have specific eligibility criteria